1.Periodic dynamic observation and analysis of cellular and humoral immunity indexes of adults infected with Omicron BA.1.
Meng Xue GAO ; Yue LEI ; Li Ru GUO ; Jiang Wen QU ; He Fei WANG ; Xiao Man LIU ; Rui LI ; Mei KONG ; Zhi Chao ZHUANG ; Zhao Lin TAN ; Xiao Yan LI ; Ying ZHANG
Chinese Journal of Preventive Medicine 2023;57(12):2117-2121
Objective: To analyze the immunological characteristics and antibody changes of patients infected with the Omicron BA.1 and evaluate the possibility of secondary infection. Methods: A total of 104 patients infected with Omicron BA.1 in the Jinnan District of Tianjin from January 8 to February 2, 2022, were included in the study. The control group and case group were matched 1∶1 based on age, sex and vaccination status. Serum was collected from the case group and control group at 3, 6 and 9 months after infection. The serum levels of interleukin4 (IL-4), IL-5 and interferon-gamma (IFN-γ), as well as the positive rates of IgG, IgG1 and IgG2, were detected by ELISA. Results: The highest concentration of IFN-γ in the case group at 6 months after infection was 145.4 pg/ml, followed by a decrease in concentration. The concentrations of IL-4 and IL-5 began to decrease at 6 months after infection (all P<0.001). There was no significant difference in the IgG2 positive rate between the case group and the control group at 6 months after BA.1 infection. However, at 9 months, there was a significant decrease compared to the control group (P=0.003). The ratio of IFN-γ/IL4 at 3 months after infection in the case group was lower than that in the control group (P<0.001). There was no significant difference in the ratio between the case group and the control group at 9 months after infection. Conclusion: The cellular immune function has been impaired at 3 months after infection with BA.1, and the specific cellular immune and humoral immune functions decrease significantly after 6 months, and the risk of secondary infection increases.
Adult
;
Humans
;
Immunity, Humoral
;
Coinfection
;
Interleukin-4
;
Interleukin-5
;
Immunoglobulin G
;
Interferon-gamma
2.New steroidal saponins from aerial parts of Paris polyphylla var. chinensis.
Zi-Lu ZHENG ; Xiao-Min TAN ; Liang-Jun GUAN ; Ru WANG ; Liang-Mian CHEN ; Zhi-Min WANG ; Hui-Min GAO
China Journal of Chinese Materia Medica 2023;48(17):4589-4597
The shortage of Paridis Rhizoma promotes comprehensive utilization and development research of waste aerial parts of the original plant. The chemical compositions of the aerial parts of Paris polyphylla var. chinensis were clarified based on the ultrahigh performance liquid chromatography tandem quadrupoles time of flight mass spectrometry(UPLC-QTOF-MS/MS) in the previous investigation, and a series of flavonoids and steroidal saponins were isolated. The present study continued the isolation and structure identification of the new potential compounds discovered based on UPLC-QTOF-MS/MS. By using silica gel, ODS, flash rapid preparation, and other column chromatography techniques, combined with prepared high performance liquid chromatography, five compounds were isolated from the 75% ethanol extract of the aerial parts of P. polyphylla var. chinensis, and their structures were identified by spectral data combined with chemical transformations, respectively, as(23S,25R)-23,27-dihydroxy-diosgenin-3-O-α-L-rhamnopyranosyl-(1→2)-[β-D-glucopyranosyl-(1→3)]-β-D-glucopyranoside(1),(25R)-26-O-β-D-glucopyranosyl-furost-5-en-3β,22α,26-triol-3-O-α-L-rhamnopyranosyl-(1→2)-[β-D-glucopyranosyl-(1→4)-α-L-rhamnopyranosyl-(1→4)]-β-D-glucopyranoside(2),(25R)-27-O-β-D-glucopyranosyl-5-en-3β,27-dihydroxyspirost-3-O-α-L-rhamnopyranosyl-(1→2)-[β-D-glucopyranosyl-(1→4)-α-L-rhamnopyranosyl-(1→4)]-β-D-glucopyranoside(3),(25R)-27-O-β-D-glucopyranosyl-5-en-3β,27-dihydroxyspirost-3-O-α-L-rhamnopyranosyl-(1→2)-[β-D-glucopyranosyl-(1→3)]-β-D-glucopyranoside(4), and aculeatiside A(5). Among them, compounds 1-4 were new ones, and compound 5 was isolated from P. polyphylla var. chinensis for the first time.
Tandem Mass Spectrometry
;
Saponins/analysis*
;
Liliaceae/chemistry*
;
Chromatography, High Pressure Liquid
;
Rhizome/chemistry*
;
Melanthiaceae
;
Molecular Structure
3.MaxEnt model-ArcGIS-based evaluation of habitat suitability of Hedysari Radix
Xin LIN ; Cheng-Yi LI ; Xiao-Cheng WEI ; Rui-Juan ZHOU ; Guang-Mao ZHANG ; Yao-Hui XIE ; Xue-Yan TAN ; Shan-Ru LIU
Chinese Traditional Patent Medicine 2023;45(12):4005-4010
AIM To evaluate the habitat suitability of Hedysari Radix based on MaxEnt model and ArcGIS.METHODS Using the MaxEnt model to screen the ecological factors affecting the distribution of Hedysari Radix,an evaluation model was thus established.ArcGIS software was used to evaluate the ecological suitability of Hedysari Radix to obtain the data about the highly suitable area,the moderate suitable area,the low suitable area and non-suitable area for its growth in China.RESULTS Hedysari Radix found its 1.29×106 km2 suitable area in China,among which the highly suitable area was 5×104 km2,mainly in Gansu Province,the moderately suitable area was 3.38×105 km2,and the low-suitable area was 9×105 km2,occupying 4.03%,26.20%and 69.77%of all,respectively.The main ecological factors affecting the distribution of Hedysari Radix were determined to be altitude,precipitation in the hottest quarter,solar radiation in September and December,seasonal temperature variation deviation and basic saturation of upper soil(0-30 cm).CONCLUSION With its result complying well with the literature records,this study provides theoretical basis for the introduction and cultivation of Hedysari Radix,and sustainable utilization of resources as well.
4.Periodic dynamic observation and analysis of cellular and humoral immunity indexes of adults infected with Omicron BA.1.
Meng Xue GAO ; Yue LEI ; Li Ru GUO ; Jiang Wen QU ; He Fei WANG ; Xiao Man LIU ; Rui LI ; Mei KONG ; Zhi Chao ZHUANG ; Zhao Lin TAN ; Xiao Yan LI ; Ying ZHANG
Chinese Journal of Preventive Medicine 2023;57(12):2117-2121
Objective: To analyze the immunological characteristics and antibody changes of patients infected with the Omicron BA.1 and evaluate the possibility of secondary infection. Methods: A total of 104 patients infected with Omicron BA.1 in the Jinnan District of Tianjin from January 8 to February 2, 2022, were included in the study. The control group and case group were matched 1∶1 based on age, sex and vaccination status. Serum was collected from the case group and control group at 3, 6 and 9 months after infection. The serum levels of interleukin4 (IL-4), IL-5 and interferon-gamma (IFN-γ), as well as the positive rates of IgG, IgG1 and IgG2, were detected by ELISA. Results: The highest concentration of IFN-γ in the case group at 6 months after infection was 145.4 pg/ml, followed by a decrease in concentration. The concentrations of IL-4 and IL-5 began to decrease at 6 months after infection (all P<0.001). There was no significant difference in the IgG2 positive rate between the case group and the control group at 6 months after BA.1 infection. However, at 9 months, there was a significant decrease compared to the control group (P=0.003). The ratio of IFN-γ/IL4 at 3 months after infection in the case group was lower than that in the control group (P<0.001). There was no significant difference in the ratio between the case group and the control group at 9 months after infection. Conclusion: The cellular immune function has been impaired at 3 months after infection with BA.1, and the specific cellular immune and humoral immune functions decrease significantly after 6 months, and the risk of secondary infection increases.
Adult
;
Humans
;
Immunity, Humoral
;
Coinfection
;
Interleukin-4
;
Interleukin-5
;
Immunoglobulin G
;
Interferon-gamma
5.Mutual Information Entropy Analysis of Compatibility of Traditional Chinese Patent Medicines Against Liver Diseases in Chinese Pharmacopoeia(2020 Edition)
Xiao-ling AN ; Shun-gang WANG ; Lin QIN ; Dao-peng TAN ; Yan-liu LU ; Yu-qi HE ; Qian-ru ZHANG ; Yan YANG
Chinese Journal of Experimental Traditional Medical Formulae 2022;28(2):199-207
ObjectiveTo investigate the compatibility rule of traditional Chinese patent medicines (TCPMs) against liver diseases through network analysis. MethodWith “liver” as the search term, TCPMs against liver diseases were retrieved from volume Ⅰ of Chinese Pharmacopoeia (2020 edition), and the basic information of them was collected. TCPMs with same Chinese medicinal materials (CMMs), usage, and indications, but different dosage forms, were unified as one formula. Mutual information entropy (MIE) of CMM couples was calculated to quantify the relationship between them, and the top 25% CMM pairs in MIE were used to construct the compatibility network, with CMM as node and the relationship between CMM pairs as the edge. Key CMM and frequently used CMM combinations were identified based on node centrality and cluster analysis, respectively. The indications of TCPMs related to the CMMs in clusters were recorded. Cytoscape 3.6.1 was employed for visualization and topology analysis of the compatibility network. ResultA total of 179 TCPMs, involving 428 CMMs, were retrieved. Angelicae Sinensis Radix, Paeoniae Radix Alba, and Glycyrrhizae Radix et Rhizoma were identified as key CMMs with high frequency, and Cuscutae Semen-Lycii Fructus, Citri Reticulatae Pericarpium-Cyperi Rhizoma, and Ecliptae Herba-Ligustri Lucidi Fructus combinations had high MIE. Furthermore, the CMMs were clustered into ten groups corresponding to different diseases which, however, all belonged to digestive diseases. ConclusionThis study unveils potential CMM pairs and common CMM combinations against liver diseases, which can serve as a reference for revealing compatibility rules of CMMs and research and development of Chinese medicine.
6.Historical Evolution of Boiling Method for Processing of Chinese Medicines
Ru GUO ; Yanhua CAO ; Xiao TAN ; Jintao FENG ; Yanfeng XIU
Chinese Journal of Experimental Traditional Medical Formulae 2022;28(24):229-236
Boiling is a common processing method of Chinese medicine. Based on the book of Summary of Processing Methods Data of Traditional Chinese Medicine in Past Dynasties, the authors consulted herbal books in all ages, combined with modern processing laws and regulations in various provinces and cities, the boiling methods and Chinese medicine varieties in ancient and modern times, judgment method of the endpoint of processing, as well as the study on boiling methods of representative Chinese medicines were compiled and analyzed. After sorting, it was found that the application of boiling methods began in the Han dynasty, enriched and developed in the Northern and Southern dynasties, Tang, Song and Yuan dynasties, and reached its heyday in the Ming and Qing dynasties. However, the number of modern boiling varieties decreased and mainly focused on toxic Chinese medicines or those that need to change or moderate their medicinal properties, indicating the development of boiling methods entered a stable period. The varieties of excipients used in the modern age mainly considered factors such as convenience of use and easy access, and the boiling degree, time and times were commonly used to judge the endpoint of boiling process. The main purposes of using boiling method for Chinese medicines were to remove impurities, remove non-medicinal parts, change or moderate the medicinal properties, and eliminate or reduce adverse reactions, which can provide a reference for carrying out the common research of boiling method for Chinese medicines.
7.Mechanism of Tibetan medicine Ershiwuwei Songshi Pills against liver injury induced by acetaminophen in mice based on Keap1/Nrf2 and TLR4/NF-κB p65 signaling pathways.
Yu-Ru SHA ; Xiao-Min LUO ; Yi DING ; Bin YANG ; Cheng-Fang JIAN ; Pu-Yang GONG ; Jian GU ; Rui TAN
China Journal of Chinese Materia Medica 2022;47(8):2049-2055
The present study investigated the mechanism of the Tibetan medicine Ershiwuwei Songshi Pills(ESP) against the liver injury induced by acetaminophen(APAP) in mice based on the kelch-like ECH-associated protein 1(Keap1)/nuclear transcription factor E2 related factor 2(Nrf2) and Toll-like receptor 4(TLR4)/nuclear factor-kappa B(NF-κB) p65 signaling pathways. Kunming mice were randomly divided into a blank control group, a model group, an N-acetyl-L-cysteine(NAC) group, and high-(400 mg·kg~(-1)), medium-(200 mg·kg~(-1)), and low-dose(100 mg·kg~(-1)) ESP groups. After 14 days of continuous administration, except for those in the control group, the mice were intraperitoneally injected with 200 mg·kg~(-1) APAP. After 12 h, the serum and liver tissues of mice were collected. Hematoxylin-eosin(HE) staining was performed on pathological sections of the liver, and the levels of aspartate aminotransferase(AST) and alanine aminotransferase(ALT) in the serum and the levels of glutathione(GSH), malondialdehyde(MDA), superoxide dismutase(SOD), catalase(CAT), myeloperoxidase(MPO), and total antioxidant capacity(T-AOC) in liver tissue homogenate were detected to observe and analyze the protective effect of ESP on APAP-induced liver injury in mice. The serum levels of tumor necrosis factor-alpha(TNF-α), interleukin-1 beta(IL-1β), and interleukin-6(IL-6) were determined by enzyme-linked immunosorbent assay(ELISA). The protein expression of Nrf2, Keap1, TLR4, and NF-κB p65 in the liver was determined by Western blot. Quantitative real-time was used to determine the mRNA expression of glutamate-cysteine ligase catalytic subunit(GCLC), glutamate-cysteine ligase regulatory subunit(GCLM), heme oxygenase-1(HO-1), and NAD(P)H dehydrogenase quinone 1(NQO-1) in the liver to explore the mechanism of ESP in improving APAP-induced liver damage in mice. As revealed by results, compared with the model group, the ESP groups showed improved liver pathological damage, decreased ALT and AST levels in the serum and MDA and MPO content in the liver, increased GSH, SOD, CAT, and T-AOC in the liver, reduced TNF-α and IL-6 levels in the serum, down-regulated expression of Keap1 in the liver cytoplasm and NF-κB p65 in the liver nucleus, up-regulated expression of Nrf2 in the liver nucleus, insignificant change in TLR4 expression, and elevated relative mRNA expression levels of antioxidant genes GCLC, GCLM, HO-1, and NQO-1. ESP can reduce the oxidative damage and inflammation caused by APAP, and the mechanism may be related to the Keap1/Nrf2 signaling pathway and the signal transduction factors on the TLR4/NF-κB p65 pathway.
Acetaminophen/toxicity*
;
Animals
;
Antioxidants/pharmacology*
;
Glutamate-Cysteine Ligase/pharmacology*
;
Glutathione
;
Interleukin-6/metabolism*
;
Kelch-Like ECH-Associated Protein 1/metabolism*
;
Liver
;
Medicine, Tibetan Traditional
;
Mice
;
NF-E2-Related Factor 2/metabolism*
;
NF-kappa B/metabolism*
;
RNA, Messenger/metabolism*
;
Signal Transduction
;
Superoxide Dismutase/metabolism*
;
Toll-Like Receptor 4/metabolism*
;
Tumor Necrosis Factor-alpha/metabolism*
8.Meaning, Efficacy and Mechanism of Huoxin Pills in Treating Coronary Heart Disease with Qi Deficiency and Blood Stasis Syndrome
Xiu-juan YANG ; Rui-xuan ZHU ; Ran XIE ; Lei YANG ; Jin-cheng CHEN ; Bao-xin XU ; Xiao-chun SHI ; Peng-qian WANG ; Hai-ru HUO ; Yu-qing TAN ; Lyu GAO ; Feng SUI
Chinese Journal of Experimental Traditional Medical Formulae 2022;28(9):205-213
Cardiovascular diseases, with high incidence and high mortality, belong to the category of "chest impediment and heart pain" in traditional Chinese medicine (TCM). Chinese medicines have unique effect on the prevention and treatment of cardiovascular diseases with little side effects. Huoxin pills, one of the National Essential Drugs, is formulated based on the basic pathogenesis of weak pulse at Yang and wiry pulse at Yin and the pathological basis of myocardial ischemia and hypoxia and used for treating angina pectoris of coronary heart disease (Qi deficiency and blood stasis syndrome). This medicine is derived from the classic famous prescription and is composed of ten precious Chinese medicinal herbs. It can replenish Qi, activate blood, and warm collaterals to diffuse impediment by enhancing myocardial contractility and cardiac output to improve micro-circulation and increase coronary blood flow, regulating immune functions, alleviating inflammation, detoxifying, and tranquilizing mind. Clinically, it is suitable for patients with angina pectoris caused by the lack of heart Yang, chest tightness, shortness of breath, palpitation, fear of cold for limbs and so on, especially for the elderly with Yang deficiency or the patients with a history of myocardial infarction. On the basis of the available research reports, this paper explains the formula meaning of Huoxin pills from the perspective of the basic pathogenesis of coronary heart disease and predicts its action targets, location and links. Furthermore, we expound the mechanism of action of Huoxin pills based on basic research and clinical evidence-based research, aiming to provide data support and evidence for the clinical application of this medicine.
9.Association between Hypertension with Hyperhomocysteinemia and Cognitive Impairment in the Kailuan Community of China: A Cross-sectional Study.
Xue Yu CHEN ; Yao YANG ; Zhao Yang TANG ; Jian LYU ; Feng Xue SHI ; Yan Ru CHEN ; Xiao Hui WANG ; Tan TAN ; Wei Jia XING ; Hai Feng HOU ; Long JI ; Xiao Dong LI ; Dong LI
Biomedical and Environmental Sciences 2021;34(7):557-561
10.Healthy China Strategy and schistosomiasis control
Jin-Ru YANG ; Ming-Xing XU ; Xiao-Dong TAN
Chinese Journal of Schistosomiasis Control 2020;32(4):419-422
This paper summarizes the changes in the policy associated with schistosmiasis control in the new era, analyzes the background of Health China Strategy and its association with the current schistosomiasis control program in China, describes several schistosomiasis control models and proposes some suggestions responding to the challenges in current schistosomiasis control program of China, so as to provide insights into the development of the effective control strategy for schistosomiasis.

Result Analysis
Print
Save
E-mail